Motta, et al.
Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.
Gastroentreology 2011 Apr;140(4):1272-82.

Buttaro C & Fruehauf JH.
Engineered E. coli as Vehicles for Targeted Therapeutics.
Curr Gene Ther. 2010 Feb;10(1):27-33.

Aigner A.
Transkingdom RNA interference (tkRNAi as a new delivery tool for therapeutic RNA.
Expert Opin Biol Ther. 2009 Dec;9(12):1533-42.

Kruhn A et al.
Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cells.
Cell Cycle. 2009 Oct 15;8(20):3349-3354.

Chen X et al.
Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.
Gastroenterology. 2009 Sep;137(3):914-23.

Nguyen T & Fruehauf JH.
Bacterial vectors for RNAi delivery.
Patho-Biotechnology. Madame Curie Bioscience Database c. 2008

Nguyen T et al.
RNAi therapeutics: An update on delivery.
Current Opinion in Molecular Therapeutics. 2008 Apr;10(2):158-167.

Li CX et al.
Delivery of RNA interference.
Cell Cycle 2006 Sept 15;5(18): 2103-2109.

Xiang S et al.
Short hairpin RNA–expressing bacteria elicit RNA interference in mammals.
Nature Biotechnology. 2006 Jun;24(6):697-702.